Gordan on Growing the Infrastructure for In-House Genomic Testing

Season 5 Episode 50  ·  Oct 14, 2021, 07:57 PM

Headliner
Share
Subscribe

Dr. Gordan discusses the advantages of in-house genomic testing, the transition from external to internal sequencing, and the anticipated effects of the move.

Share
Subscribe
Next
Ilson Delves Into the Development of Checkpoint Inhibition in Gastric/GEJ Cancers
Top episodes
DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology
by OncLive® On Air
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air